CN Patent

CN1249687A — 用于降低眼高压的组合物和方法

Assigned to Novartis AG · Expires 2000-04-05 · 26y expired

What this patent protects

一种改进的眼用组合物,内含前列腺素活性剂,该组合物尤其可用于降低与青光眼有关的眼内压力。利用所公开的组合物,提高了IOP降低效果和防腐效果,降低了添加剂浓度,该组合物包括一种前列腺素活性剂(例如异丙基乌诺前列酮,它是一种F型前列腺素的代谢物),以及所选择的非离子型表面活性剂、防腐剂和非离子型张度添加剂。

USPTO Abstract

一种改进的眼用组合物,内含前列腺素活性剂,该组合物尤其可用于降低与青光眼有关的眼内压力。利用所公开的组合物,提高了IOP降低效果和防腐效果,降低了添加剂浓度,该组合物包括一种前列腺素活性剂(例如异丙基乌诺前列酮,它是一种F型前列腺素的代谢物),以及所选择的非离子型表面活性剂、防腐剂和非离子型张度添加剂。

Drugs covered by this patent

Patent Metadata

Patent number: CN1249687A
Jurisdiction: CN
Classification: —
Expires: 2000-04-05
Drug substance claim: No
Drug product claim: No
Assignee: Novartis AG
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.